Scholars@Duke

Bevacizumab in colorectal cancer.

Publication ,  Journal Article
Sonpavde, G
Published in: N Engl J Med
October 14, 2004
Published version (DOI) Link to item

Duke Scholars

Herbert Ira Hurwitz
Author Herbert Ira Hurwitz Medicine, Medical Oncology

Published In

N Engl J Med

DOI

10.1056/NEJM200410143511622

EISSN

1533-4406

Publication Date

October 14, 2004

Volume

351

Issue

16

Start / End Page

1690 / 1691

Location

United States

Related Subject Headings

  • Research Design
  • Randomized Controlled Trials as Topic
  • Neoplasm Metastasis
  • Humans
  • General & Internal Medicine
  • Disease Progression
  • Cross-Over Studies
  • Colorectal Neoplasms
  • Bevacizumab
  • Antineoplastic Combined Chemotherapy Protocols
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sonpavde, G. (2004). Bevacizumab in colorectal cancer. N Engl J Med, 351(16), 1690–1691. https://doi.org/10.1056/NEJM200410143511622
Sonpavde, Guru. “Bevacizumab in colorectal cancer.” N Engl J Med 351, no. 16 (October 14, 2004): 1690–91. https://doi.org/10.1056/NEJM200410143511622.
Sonpavde G. Bevacizumab in colorectal cancer. N Engl J Med. 2004 Oct 14;351(16):1690–1.
Sonpavde, Guru. “Bevacizumab in colorectal cancer.” N Engl J Med, vol. 351, no. 16, Oct. 2004, pp. 1690–91. Pubmed, doi:10.1056/NEJM200410143511622.
Sonpavde G. Bevacizumab in colorectal cancer. N Engl J Med. 2004 Oct 14;351(16):1690–1691.

Published In

N Engl J Med

DOI

10.1056/NEJM200410143511622

EISSN

1533-4406

Publication Date

October 14, 2004

Volume

351

Issue

16

Start / End Page

1690 / 1691

Location

United States

Related Subject Headings

  • Research Design
  • Randomized Controlled Trials as Topic
  • Neoplasm Metastasis
  • Humans
  • General & Internal Medicine
  • Disease Progression
  • Cross-Over Studies
  • Colorectal Neoplasms
  • Bevacizumab
  • Antineoplastic Combined Chemotherapy Protocols